rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-7-22
|
pubmed:abstractText |
This retrospective longitudinal cohort study compared the virological and immunological responses to highly active antiretroviral therapy containing either efavirenz or lopinavir/ritonavir in previously antiretroviral-naive HIV-infected patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0305-7453
|
pubmed:author |
pubmed-author:AriciClaudioC,
pubmed-author:CarosiGiampieroG,
pubmed-author:LadisaNicolettaN,
pubmed-author:MASTER Cohort,
pubmed-author:MaggioloFrancoF,
pubmed-author:MinoliLorenzoL,
pubmed-author:OraniAnna MariaAM,
pubmed-author:ParaninfoGiuseppeG,
pubmed-author:PatroniAndreaA,
pubmed-author:PierottiPieraP,
pubmed-author:SighinolfiLauraL,
pubmed-author:SuterFredyF,
pubmed-author:TinelliCarmineC,
pubmed-author:TortiCarloC
|
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
190-5
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15917286-Adult,
pubmed-meshheading:15917286-Anti-HIV Agents,
pubmed-meshheading:15917286-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15917286-Benzoxazines,
pubmed-meshheading:15917286-CD4 Lymphocyte Count,
pubmed-meshheading:15917286-Cohort Studies,
pubmed-meshheading:15917286-Drug Therapy, Combination,
pubmed-meshheading:15917286-Female,
pubmed-meshheading:15917286-Follow-Up Studies,
pubmed-meshheading:15917286-HIV Seropositivity,
pubmed-meshheading:15917286-Humans,
pubmed-meshheading:15917286-Longitudinal Studies,
pubmed-meshheading:15917286-Lopinavir,
pubmed-meshheading:15917286-Male,
pubmed-meshheading:15917286-Middle Aged,
pubmed-meshheading:15917286-Oxazines,
pubmed-meshheading:15917286-Pyrimidinones,
pubmed-meshheading:15917286-Retrospective Studies,
pubmed-meshheading:15917286-Ritonavir
|
pubmed:year |
2005
|
pubmed:articleTitle |
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
|
pubmed:affiliation |
Institute for Infectious and Tropical Diseases, University of Brescia, Italy. torti.carlo@libero.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|